Adverse effects of cigarette smoke and induction of oxidative stress in cardiomyocytes and vascular endothelium

Current Pharmaceutical Design

Volumn 16, Issue 23, 2010, Pages 2551-2558

  Carver, Anabel Varela ^a   Parker, Howard ^a   Kleinert, Christina ^a   Rimoldi, Ornella ^a,b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Cardiomyocyte; Endothelium; Oxidative stress; Smoking

Indexed keywords

ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DNA DAMAGE; ENERGY METABOLISM; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; MITOGENESIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOKING HABIT; TELOMERE; VASCULAR ENDOTHELIUM;

ANIMALS; DNA, MITOCHONDRIAL; ENDOTHELIUM, VASCULAR; HUMANS; MYOCYTES, CARDIAC; OXIDATIVE STRESS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 77955597014     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210792062830     Document Type: Article

References (121)

1. American Heart Association. Heart and stroke statistical update. Dallas, Texas: American Heart Association 2000; pp. 1-32.
2. Jia L, Liu Z, Sun L, et al. Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in rpe cells: protection by (R)-α-lipoic acid. Invest Opthal Vis Sci 2007; 48(1): 339-48.
3. Valavanidis A, Vlachogianni T, Fiotakis K. Tobacco smoke: Involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health 2009; 6: 445-62.
4. Mayhan WG, Sharpe GM. Acute and chronic treatment with nicotine impairs reactivity of arterioles in response to activation of potassium channels. J Cardiovasc Pharmacol 2002; 39: 695-703.
5. Fang Q, Sun H, Mayhan WG. Impairment of nitric oxide synthasedependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol 2003; 284: H528-34.
6. Neunteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 2002; 39: 251-6.
7. Tonnessen BH, Severson SR, Hurt RD, et al. Modulation of nitricoxide synthase by nicotine. J Pharmacol Exp Ther 2000; 295: 601-6.
8. Saijonmaa O, Nyman T, Fyhrquist F. Regulation of angiotensinconverting enzyme production by nicotine in human endothelial cells. Am J Physiol Heart Circ Physiol 2005; 289: H2000-4.
9. Zhang S, Day I, Ye S. Nicotine induced changes in gene expression by human coronary artery endothelial cells. Atherosclerosis 2001; 154: 277-83.
10. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271(5 Pt 1): C1424-37.
11. Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in LDL. Circulation 1998; 97: 2012-6.
12. Lekakis J, Papamichael C, Vemmos C, Stamatelopoulos K, Voutsas A, Stamatelopoulos S. Effect of acute cigarette smoking on endothelial-dependent arterial dilatation in normal subjects. J Am Cardiol 1998; 81: 1225-8.
13. Du XL, Edelstein D, Rossetti L, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexominase pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000; 97: 12222-26.
14. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-90.
15. Rosen P, Nawroth PP, King G, et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN. Diabetes Metab ResRev 2001; 17: 189-212.
16. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
17. Penumathsa SV, Maulik N. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol 2009; 87: 275-86.
18. Serpillon S, Floyd BC, Gupte RS, et al. Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase- derived NADPH. Am J Physiol Heart Circ Physiol 2009; 297: H153-62.
19. Wei Y, Clark SE, Morris EM, et al. Angiotensin II-induced nonalcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats. J Hepatol 2008; 49(3): 417-28.
20. Whaley-Connell A, Govindarajan G, Habibi J, et al. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat. Am J Physiol Endocrinol Metab 2007; 293: E355-63.
21. Da Ros R, Assaloni R, Ceriello A. antioxidant therapy in diabetic complications: what is new? Curr Vasc Pharmacol 2004; 2(4): 335-41.
22. Hwang JT, Kwon DY, Yoon SH. AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. N Biotechnol 2009; 26(1-2): 17-22.
23. Meurrens K, Ruf S, Ross G, et al. Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats. Cardiovasc Res 2007; 76: 311-22.
24. Pacher P, Szabó C. Role of Poly(ADP-ribose)polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 2007; 25: 235-60.
25. Pacher P, Szabo C. Role of the peroxynitite-poly(ADPribose) polymerase pathway in human disease. Am J Pathol 2008; 173: 2-13.
26. Palfi A, Toth A, Kulcsar Gy, et al. The role of Akt and mitogenactivated protein kinase systems in the protective effect of poly(ADP-ribose)polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts. J Pharmacol Exp Ther 2005; 315: 273-82.
27. Bartha E, Solti I, Kereskai L, et al. PARP inhibition delays transition of hypertensive cardiomyopathy to heart failure in spontaneously hypertensive rats. Cardiovasc Res 2009; 83: 501-10.
28. Ushio-Fukai M, Zafari AM, Fukui T, et al. p22phox Is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996; 271: 23317-21.
29. von Harsdorf R, Li PF, Dietz R. Signaling pathways in reactive oxygen species-induced cardiocardiomyocyte apoptosis. Circulation 1999; 99: 2934-41.
30. Berry C, Hamilton CA, Brosnan MJ, et al. investigation into the sources of superoxide in human blood vessels; Angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000; 101: 2206-12.
31. Frustaci A, Kajstura J, Chimenti C, et al. myocardial cell death in human diabetes. Circ Res 2000; 87: 1123-32.
32. Houdi AGA, Dowell RT, Diana JN. cardiovascular responses to cigarette smoke exposure in restrained conscious rats. J Pharmacol Exp Therap 1995; 275; 646-53.
33. Baines, CP, Kaiser, RA, Purcell, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005; 434, 658-62.
34. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003; 93: 292-301.
35. Brookes PS, Yoon Y, Robotham JL, et al. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004; 287: C817-833.
36. Korge P, Goldhaber JI, Weiss JN. Phenylarsine oxide induce mitochondrial permeability transition, hypercontracture, and cardiac cell death. Am J Physiol Heart Circ Physiol 2001; 280: H2203-13.
37. Nakagawa T, Shimizu S, Watanabe T, et al. Cyclophilin Ddependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434: 652-8.
38. Yamada S, Zhang XQ, Kadono T, et al. Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations. Toxicol Appl Pharmacol 2009; 236: 71-7.
39. Dhalla N, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18(6): 655-73.
40. Josephson RA, Silverman HS, Lakatta EG, et al. Study of the mechanisms of hydrogen peroxide and hydroxyl free radicalinduced cellular injury and calcium overload in cardiac cardiomyocytes. J Biol Chem 1991; 266 (4): 2354-61.
41. Valencia A, Moran J. Reactive oxygen species induce different cell death mechanisms in cultured neurons. Free Rad Biol Med 2004; 36(9): 1112-25.
42. Siwik DA, Tzortzis JD, Pimental DR, et al. Inhibition of copperzinc superoxide dismutase induces cell growth, hypertrophic phenotype and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 1999; 85: 147-53.
43. Pimentel DR, Amin JK, Xiao L, et al. Reactive oxygen species mediate amplitutde-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001; 89: 453-60.
44. Sugden PH, Clerk A. 'Stress-responsive' mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 1998; 83(4): 345-52.
45. Gu L, Pandey V, Geenen DL, et al. Cigarette smoke-induced left ventricular remodelling is associated with activation of mitogenactivated protein kinases. Eur J Heart Fail 2008; 10: 1057-64.
46. Knight-Lozano CA, Young CG, et al. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002; 105: 849-54.
47. Fleury C, Mignotte B, Vayssière JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002; 84: 131-41.
48. Sawyer DB, Siwik DA, Xiao L, et al. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002; 34: 379-88.
49. Nakamura K, Fushimi K, Kouchi H, et al. inhibitory effects of antioxidants on neonatal rat cardiac cardiomyocyte hypertrophy induced by tumor necrosis factor-a and angiotensin II. Circulation 1998; 98: 794-9.
50. Olivetti G, Capasso JM, Sonnenblick EH, et al. Side-to-side slippage of cardiomyocytes participates in ventricular wall remodelling acutely after myocardial infarction in rats. Circ Res 1990; 67: 23-34.
51. Feil R, Lohmann SM, de Jonge H, et al. Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res 2003; 93: 907-16.
52. Hare JM. Nitroso-redox balance in the cardiovascular system. N Engl J Med 2004; 351: 2112-4.
53. Paolocci N, Ekelund UE, Isoda T, et al. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation. Am J Physiol Heart Circ Physiol 2000; 279: H1982-8.
54. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500-8.
55. Katori T, Donzelli S, Tocchetti CG, et al. Peroxnitrite and myocardial contractility: in vivo versus in vitro effects. Free Radic Biol Med 2006; 41: 1606-18.
56. Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev 2002; 54: 619-34.
57. Pacher P, Schulz R, Liaudet L, et al. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci 2005; 26: 302-10
58. Hassoun PM, Yu FS, Zulueta JJ, et al. Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. Am J Physiol 1995; 268: L809-17.
59. Cote CG, Yu FS, Zulueta JJ, et al. Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am J Physiol 1996; 271: L869-74.
60. Shinyashiki M, Pan CJ, Lopez BE, et al. Inhibition of the yeast metal reductase heme protein fre1 by nitric oxide (NO): a model for inhibition of NADPH oxidase by NO. Free Radic Biol Med 2004; 37: 713-23.
61. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90: 1116-21.
62. Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac cardiomyocytes. Antioxid Redox Signal 2003; 5: 731-40.
63. Wei S, Rothstein EC, Fliegel L, et al. Differential MAP kinase activation and Na+/H+ exchanger phosphorylation by H2O2 in rat cardiac cardiomyocytes. Am J Physiol Cell Physiol 2001; 281: C1542-50.
64. Sabri A, Byron KL, Samarel AM, et al. Hydrogen peroxide activates mitogen-activated protein kinases and Na+ H+ exchange in neonatal rat cardiac cardiomyocytes. Circ Res 1998; 82: 1053-62.
65. Aikawa R, Nagai T, Tanaka M, et al. Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. Biochem Biophys Res Commun 2001; 289: 901-7.
66. Tu VC, Bahl JJ, Chen QM. Signals of oxidant-induced myocytes hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. J Pharmacol Exp Ther 2002; 300: 1101-10.
67. Kwon SH, Pimentel DR, Remondino A, et al. H2O2 regulates cardiac cardiomyocyte phenotype via concentration dependent activation of distinct kinase pathways. J Mol Cell Cardiol 2003; 35: 615-21.
68. Xiao L, Pimental DR, Amin JK, et al. MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular cardiomyocytes. J Mol Cell Cardiol 2001; 33: 779-87.
69. Tanaka K, Honda M, Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac cardiomyocyte. J Am Coll Cardiol 2001; 37: 676-85.
70. Delbosc S, Cristol JP, Descomps B, et al. Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress. Hypertension 2002; 40: 142-7.
71. Amin JK, Xiao L, Pimental DR, et al. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular cardiomyocytes. J Mol Cell Cardiol 2001; 33: 131-9.
72. Liao R, Siwik DA, Colucci WS. Alpha-adrenergic receptorstimulated hypertrophy in adult rat ventricular cardiomyocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 2005; 111: 1192-8.
73. Hirotani S, Otsu K, Nishida K, et al. Involvement of nuclear factorkappaB and apoptosis signal-regulating kinase 1 in G-proteincoupled receptor agonist-induced cardiomyocytes hypertrophy. Circulation 2002; 105: 509-15.
74. Cheng TH, Cheng PY, Shih NL, et al. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 2003; 42: 1845-54.
75. Spinale FG. Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases. Circ Res 2002; 91: 1082-4.
76. Sorescu D, Griendling KK. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 2002; 8: 132-40.
77. Siwik DA, Pagano PJ, Colucci WS. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 2001; 280: C53-60.
78. Siwik DA, Colucci WS. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 2004; 9: 43-51.
79. Cesselli D, Jakoniuk I, Barlucchi L, et al. Oxidative stressmediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001; 89: 279-86.
80. Yamaguchi O, Higuchi Y, Hirotani S, et al. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci USA 2003; 100: 15883-8.
81. Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006; 71: 310-21.
82. Kawakami M, Okabe E. Superoxide anion radical-triggered Ca2+ release from cardiac sarcoplasmic reticulum through ryanodine receptor Ca2+ channel. Mol Pharmacol 1998; 53: 497-503.
83. Fearon IM, Palmer AC, Balmforth AJ, et al. Modulation of recombinant human cardiac L-type Ca2+ channel alpha1C subunits by redox agents and hypoxia. J Physiol 1999; 514: 629-37.
84. Xu KY, Zweier JL, Becker LC. Hydroxyl radical inhibits sarcoplasmic reticulum Ca2+-ATPase function by direct attack on the ATP binding site. Circ Res 1997; 80: 76-81.
85. Adachi T, Weisbrod RM, Pimentel DR, et al. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 2004; 10: 1200-7.
86. Goette A, Lendeckel U, Kuckenbecker A, et al. Cigarette smoking induces atrial fibrillosis in humans via nicotine. Heart 2007; 93: 1056-63.
87. Adamopoulos D, van de Borne P, Argacha JF. New insights into the sympathetic, endothelial and coronary effects of nicotine. Clin Exp Pharmacol Physiol 2008; 35: 458-63.
88. Zhu BQ, Parmley WW. Hemodynamic and vascular effects of active and passive smoking. Am Heart J 1995; 130: 1270-5
89. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-487.
90. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-60.
91. Vaziri H, Dragowska W, Allsopp RC, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-18.
92. Vaziri H, Dragowska W, Allsopp R, et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-60.
93. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995; 219: 130-6.
94. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995; 92: 11190-4.
95. Samani NJ, Boultby R, Butler RB, et al. Telomere shortening in atherosclerosis. Lancet 2001; 358: 472-3.
96. Brouilette S, Singh RK, Thompson JR, et al. White cell telomere length and risk of myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23 842-6.
97. Cawthon R, Smith K, O'Brien E, et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393-5.
98. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-55.
99. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-4.
100. Barua RS, Ambrose JA, Eales-Reynolds LJ, et al. dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 2001; 104: 1905-10.
101. Kugiyama K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996; 28: 1161-7.
102. Sumida H, Watanabe H, Kugiyama K, et al. Does passive smoking impair endothelium-dependent coronary artery dilation in women? J Am Coll Cardiol 1998; 31: 811-5.
103. Mayhan WG, Patel KP. Effect of nicotine on endotheliumdependent arteriolar dilatation in vivo. Am J Physiol 1997; 272: H2337-42.
104. Mayhan WG, Sharpe GM. Effect of cigarette smoke extract on arteriolar dilatation in vivo. J Appl Physiol 1996; 81: 1996-2003.
105. McVeigh GE, Lemay L, Morgan D, et al. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol 1996; 78: 668-72.
106. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, et al. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 2000; 102: 1233-8.
107. Tsuchiya M, Asada A, Kasahara E, et al. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 2002; 105: 1155-7.
108. Orosz Z, Csiszar A, Labinskyy N, et al. Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am J Physiol Heart Circ Physiol 2007; 292: H130-9.
109. Bernhard D, Csordas A, Henderson B, et al. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J 2005; 19: 1096-107.
110. Rahman MR, Elmi S, Chang TKH, et al. Increased vascular contractility in isolated vessels from cigarette smoking rats is mediated by basal endothelin release. Vasc Pharmacol 2007; 46: 35-42.
111. Di Luozzo G, Pradhan S, Dhadwal AK, et al. Nicotine induces mitogen-activated protein kinase dependent vascular smooth muscle cell migration Atherosclerosis 2005; 178: 271-7.
112. Matsumoto M, Dimayuga PC, Wang C, et al. Exogenous heat shock protein-70 inhibits cigarette smoke-induced intimal thickening. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1320-7.
113. Raij L, DeMaster EG, Jaimes EA. Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J Hypertens 2001; 19: 891-7.
114. Anazawa T, Dimayuga PC, Li H, et al. Effect of exposure to cigarette smoke on carotid artery intimal thickening; The role of inducible NO synthase. Arterioscler Thromb Vasc Biol 2004; 24: 1652-8.
115. Soejima K, Traber LD, Schmalstieg FC, et al. Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury. Am J Respir Crit Care Med 2001; 163: 745-52.
116. Finder JD, Petrus JL, Hamilton A, et al. Signal transduction pathways of IL-1b-mediated iNOS in pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2001; 281: L816-23.
117. Martinet W, Knaapen WMW, De Meyer RYG, et al. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res 2001; 88: 733-9.
118. Kunitomo M, Yamaguchi Y, Kagota S, et al. Biochemical evidence of atherosclerosis progression mediated by increased oxidative stress in apolipoprotein e-deficient spontaneously hyperlipidemic mice exposed to chronic cigarette smoke. J Pharmacol Sci 2009; 110: 354-61.
119. Martinet W, Knaapen WMW, De Meyer RYG, et al. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002; 106: 927-32.
120. Gautier EL, Huby T, Witztum JL, et al. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation 2009; 119: 1795-804.
121. Tan D, Goerlitz DS, Dumitrescu GR, et al. Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells. Carcinogenesis 2008; 29: 6: 1170-7.